Matches in Nanopublications for { ?s ?p "[Using an in vitro transcription system based on the HLA-DRA promoter, we show here that extracts from RFX-deficient cells from patients with BLS (BLS cells) in groups B and C, which are transcriptionally inactive in this assay, can be complemented to full transcriptional activity by the purified RFX.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP864192.RApO5YPzTR2g1xTXWIO4lJEB7cy0W2Gq9t__yjiR0Nx_w130_assertion description "[Using an in vitro transcription system based on the HLA-DRA promoter, we show here that extracts from RFX-deficient cells from patients with BLS (BLS cells) in groups B and C, which are transcriptionally inactive in this assay, can be complemented to full transcriptional activity by the purified RFX.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864192.RApO5YPzTR2g1xTXWIO4lJEB7cy0W2Gq9t__yjiR0Nx_w130_provenance.
- NP438180.RA3fHQpBKxJsYC9J7ahb_BTyWeeUI6B5RZkyBSKlh15nc130_assertion description "[Using an in vitro transcription system based on the HLA-DRA promoter, we show here that extracts from RFX-deficient cells from patients with BLS (BLS cells) in groups B and C, which are transcriptionally inactive in this assay, can be complemented to full transcriptional activity by the purified RFX.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438180.RA3fHQpBKxJsYC9J7ahb_BTyWeeUI6B5RZkyBSKlh15nc130_provenance.
- NP454498.RAwEamnnahK8fIqTG6NfYi_OGhUq-jDEObC_0WIaBTY9s130_assertion description "[Using an in vitro transcription system based on the HLA-DRA promoter, we show here that extracts from RFX-deficient cells from patients with BLS (BLS cells) in groups B and C, which are transcriptionally inactive in this assay, can be complemented to full transcriptional activity by the purified RFX.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454498.RAwEamnnahK8fIqTG6NfYi_OGhUq-jDEObC_0WIaBTY9s130_provenance.
- NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_assertion description "[Using an in vitro transcription system based on the HLA-DRA promoter, we show here that extracts from RFX-deficient cells from patients with BLS (BLS cells) in groups B and C, which are transcriptionally inactive in this assay, can be complemented to full transcriptional activity by the purified RFX.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454502.RAE-zT1RIU8tsQ1PBMgyD75s8wk7Q08J35kF66m5btUZM130_provenance.
- NP1327515.RAGbzrl4ynQjXTPqo3ymxZ1ZnLfNypj6r0CphlLHjCDDs130_assertion description "[Using an in vitro transcription system based on the HLA-DRA promoter, we show here that extracts from RFX-deficient cells from patients with BLS (BLS cells) in groups B and C, which are transcriptionally inactive in this assay, can be complemented to full transcriptional activity by the purified RFX.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327515.RAGbzrl4ynQjXTPqo3ymxZ1ZnLfNypj6r0CphlLHjCDDs130_provenance.
- NP1327516.RA_kE7QhJku7U6Nyk7_NS6vJzYejJBLkABEvzM5r4kHQ8130_assertion description "[Using an in vitro transcription system based on the HLA-DRA promoter, we show here that extracts from RFX-deficient cells from patients with BLS (BLS cells) in groups B and C, which are transcriptionally inactive in this assay, can be complemented to full transcriptional activity by the purified RFX.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327516.RA_kE7QhJku7U6Nyk7_NS6vJzYejJBLkABEvzM5r4kHQ8130_provenance.